Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries.

Martirosyan L, Paget WJ, Jorgensen P, Brown CS, Meerhoff TJ, Pereyaslov D, Mott JA; EuroFlu group..

BMC Infect Dis. 2012 Feb 10;12:36. doi: 10.1186/1471-2334-12-36.

2.

Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection.

Staneková Z, Mucha V, Sládková T, Blaškovičová H, Kostolanský F, Varečková E.

Influenza Other Respir Viruses. 2012 Nov;6(6):389-95. doi: 10.1111/j.1750-2659.2011.00328.x. Epub 2012 Jan 12.

3.

Evaluation of clinical specimens for Rickettsia, Bartonella, Borrelia, Coxiella, Anaplasma, Franciscella and Diplorickettsia positivity using serological and molecular biology methods.

Sekeyova Z, Subramanian G, Mediannikov O, Diaz MQ, Nyitray A, Blaskovicova H, Raoult D.

FEMS Immunol Med Microbiol. 2012 Feb;64(1):82-91. doi: 10.1111/j.1574-695X.2011.00907.x. Epub 2011 Dec 13.

4.

Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe.

Amato-Gauci A, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, Penttinen P, Nicoll A; European Influenza Surveillance Network EISN..

Euro Surveill. 2011 Jun 30;16(26). pii: 19903. Review. No abstract available.

5.

Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009.

Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A; ECDC influenza surveillance group.; national coordinators for influenza surveillance..

Euro Surveill. 2010 Dec 9;15(49). pii: 19740. Erratum in: Euro Surveill. 2011;16(3). pii: 19769. Gunson, Rory [added].

6.

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.

Krejnusová I, Gocníková H, Bystrická M, Blaskovicová H, Poláková K, Yewdell J, Bennink J, Russ G.

Arch Virol. 2009;154(10):1599-604. doi: 10.1007/s00705-009-0479-5. Epub 2009 Aug 12.

7.

Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries.

ECDC working group on influenza A(H1N1)v..

Euro Surveill. 2009 Jun 11;14(23):19238.

8.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme..

Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.

9.

Polymerase chain reaction (PCR)--an efficient tool for diagnosis of influenza and acute respiratory illnesses during influenza season.

Mad'arová L, Feiková S, Kissová R, Klement C, Blaskovicová H, Takác B, Dluholucký S.

Cent Eur J Public Health. 2008 Jun;16(2):59-64.

10.

A fatal case of psittacosis in Slovakia, January 2006.

Kovácová E, Majtán J, Botek R, Bokor T, Blaskovicová H, Solavová M, Ondicová M, Kazár J.

Euro Surveill. 2007 Aug 2;12(8):E070802.1. No abstract available.

PMID:
17880885
11.

Evaluation of clinical specimens for influenza A virus positivity using various diagnostic methods.

Varecková E, Blaskovicová H, Gocník M, Mikas J, Adamcáková J, Fislová T, Kostolanský F, Mucha V.

Acta Virol. 2006;50(3):181-6.

PMID:
17131937
12.

Changes in the reactivity of the immune system of children after the influenza A infection.

Melter J, Pohanka V, Melterová K, Belobradová M, Blaskovicová H, Mucha V, Kostolanský F, Varecková E, Ciampor F.

Acta Virol. 2006;50(2):145-7. No abstract available.

PMID:
16808334
13.

[Influenza and influenza-like acute respiratory diseases in Slovakia in the 1999-2000 season].

Kristufkova Z, Blaskovicova H.

Bratisl Lek Listy. 2000;101(11):603-10. Slovak.

PMID:
11218957
14.

[Prenatal virus infections and orofacial clefts].

Molnárová A, Brozman M, Schwanzerová I, Blaskovicová H, Stancek D, Srámeková R, Hatiarová Z, Mayerová A, Mracnová D.

Bratisl Lek Listy. 1992 Sep;93(9):469-76. Slovak.

PMID:
1288828
15.

Possible teratogenic potential of certain virus infections as related to patients with orofacial cleft.

Molnárová A, Brozman M, Schwanzerová I, Schwanzer V, Blaskovicová H, Srámeková R, Hatiarová Z, Mayerová A.

Acta Virol. 1991 Apr;35(2):204. No abstract available.

PMID:
1681721
16.

[Initial results of monitoring hepatitis C virus antibodies in selected population groups in Slovakia. Preliminary results].

Schwanzerová I, Masár I, Blaskovícová H, Schwanzer V.

Cesk Epidemiol Mikrobiol Imunol. 1991 Jan;40(1):60-1. Slovak. No abstract available.

PMID:
1707349
17.

Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alpha.

Stancek D, Janota S, Blaskovicová H, Hajnická V, Laktis K, Sudová J, Cvopová A, Klement C.

Acta Virol. 1990 Sep;34(5):467-76.

PMID:
1981457
18.

Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.

Stancek D, Hajnická V, Blaskovicová H, Sudová J, Laktis K, Janota S, Jezek P.

Acta Virol. 1990 Sep;34(5):457-66.

PMID:
1981456
19.

Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection.

Stancek D, Blaskovicová H, Hajnická V, Husár K, Holenová Z, Mathernová V, Sudová J, Laktis K, Spanárová V.

Acta Virol. 1987 May;31(3):234-42.

PMID:
2888287
20.

[Etiological and immunopathological markers in hepatitis B patients in the early convalescence stage during the development of chronic liver involvement].

Stancek D, Blaskovicová H, Shudova Iu, Zakharova M, Shpanarova V.

Vopr Virusol. 1987 Mar-Apr;32(2):222-4. Russian.

PMID:
2440187

Supplemental Content

Loading ...
Support Center